CN111635390A - Low-foam alpha-tocopherol surfactant and preparation method thereof - Google Patents

Low-foam alpha-tocopherol surfactant and preparation method thereof Download PDF

Info

Publication number
CN111635390A
CN111635390A CN202010615372.0A CN202010615372A CN111635390A CN 111635390 A CN111635390 A CN 111635390A CN 202010615372 A CN202010615372 A CN 202010615372A CN 111635390 A CN111635390 A CN 111635390A
Authority
CN
China
Prior art keywords
compound
tocopherol
alpha
surfactant
foam
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202010615372.0A
Other languages
Chinese (zh)
Inventor
宋冰蕾
陈豪
陈钊
庞淑敬
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Jiangnan University
Original Assignee
Jiangnan University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jiangnan University filed Critical Jiangnan University
Priority to CN202010615372.0A priority Critical patent/CN111635390A/en
Publication of CN111635390A publication Critical patent/CN111635390A/en
Pending legal-status Critical Current

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
    • C07D311/70Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with two hydrocarbon radicals attached in position 2 and elements other than carbon and hydrogen in position 6
    • C07D311/723,4-Dihydro derivatives having in position 2 at least one methyl radical and in position 6 one oxygen atom, e.g. tocopherols
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67Vitamins
    • A61K8/678Tocopherol, i.e. vitamin E
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/10Washing or bathing preparations
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K23/00Use of substances as emulsifying, wetting, dispersing, or foam-producing agents
    • CCHEMISTRY; METALLURGY
    • C11ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11DDETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D1/00Detergent compositions based essentially on surface-active compounds; Use of these compounds as a detergent
    • C11D1/02Anionic compounds
    • C11D1/04Carboxylic acids or salts thereof
    • C11D1/06Ether- or thioether carboxylic acids
    • CCHEMISTRY; METALLURGY
    • C23COATING METALLIC MATERIAL; COATING MATERIAL WITH METALLIC MATERIAL; CHEMICAL SURFACE TREATMENT; DIFFUSION TREATMENT OF METALLIC MATERIAL; COATING BY VACUUM EVAPORATION, BY SPUTTERING, BY ION IMPLANTATION OR BY CHEMICAL VAPOUR DEPOSITION, IN GENERAL; INHIBITING CORROSION OF METALLIC MATERIAL OR INCRUSTATION IN GENERAL
    • C23GCLEANING OR DE-GREASING OF METALLIC MATERIAL BY CHEMICAL METHODS OTHER THAN ELECTROLYSIS
    • C23G1/00Cleaning or pickling metallic material with solutions or molten salts
    • CCHEMISTRY; METALLURGY
    • C23COATING METALLIC MATERIAL; COATING MATERIAL WITH METALLIC MATERIAL; CHEMICAL SURFACE TREATMENT; DIFFUSION TREATMENT OF METALLIC MATERIAL; COATING BY VACUUM EVAPORATION, BY SPUTTERING, BY ION IMPLANTATION OR BY CHEMICAL VAPOUR DEPOSITION, IN GENERAL; INHIBITING CORROSION OF METALLIC MATERIAL OR INCRUSTATION IN GENERAL
    • C23GCLEANING OR DE-GREASING OF METALLIC MATERIAL BY CHEMICAL METHODS OTHER THAN ELECTROLYSIS
    • C23G5/00Cleaning or de-greasing metallic material by other methods; Apparatus for cleaning or de-greasing metallic material with organic solvents
    • C23G5/02Cleaning or de-greasing metallic material by other methods; Apparatus for cleaning or de-greasing metallic material with organic solvents using organic solvents
    • C23G5/032Cleaning or de-greasing metallic material by other methods; Apparatus for cleaning or de-greasing metallic material with organic solvents using organic solvents containing oxygen-containing compounds

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Materials Engineering (AREA)
  • Mechanical Engineering (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Metallurgy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Birds (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Wood Science & Technology (AREA)
  • Emulsifying, Dispersing, Foam-Producing Or Wetting Agents (AREA)
  • Pyrane Compounds (AREA)
  • Cosmetics (AREA)

Abstract

The invention discloses a low-foam alpha-tocopherol surfactant and a preparation method thereof, belonging to the field of synthesis and application of natural product surfactants. The invention provides an alpha-tocopherol surfactant and a preparation method thereof, wherein the alpha-tocopherol surfactant has extremely low foamability and foam stability, the initial foam volume is 0.5ml, and the foam half-life period is less than 3 seconds. The raw material alpha-tocopherol used for preparing the alpha-tocopherol surfactant has the advantages of reproducibility, biodegradability, multiple functions, easy modification of structure and the like, and the excellent performance of the surfactant can enable the surfactant to be applied to the fields of metal cleaning agents, personal washing and nursing articles and the like.

Description

Low-foam alpha-tocopherol surfactant and preparation method thereof
Technical Field
The invention relates to a low-foam alpha-tocopherol surfactant and a preparation method thereof, belonging to the field of synthesis and application of natural product surfactants.
Background
The low-foam surfactant is widely applied to industrial cleaning and personal care, and most of the traditional low-foam surfactants are nonionic surfactants of ethylene oxide-propylene oxide block polyether. Such surfactants are made primarily from petrochemicals. Under the condition of the increasing shortage of petroleum resources, the biological reduction foam type surfactant prepared by taking biomass resources as raw materials is the focus of attention of people at present.
Vitamin E is an important biological antioxidant in mammalian cell membranes, and its antioxidant action is essential to protect the integrity of the biological membrane — scavenging free radicals and breaking down further oxidative chain reactions, preventing oxidation of unsaturated fatty acids. In addition, vitamin E can also alleviate the negative effects of infectious diseases by enhancing cellular and humoral immunity. In recent years, vitamin E and derivatives thereof are found to have obvious effects on preventing Alzheimer's disease, inducing cancer cell specific apoptosis and inhibiting tumor angiogenesis. Vitamin E is a general term of four tocopherols and four tocotrienols, and alpha-tocopherol is considered as the most important active compound of the tocopherol and has the characteristics of low price, easy obtainment, regeneration, biodegradability and the like. From the perspective of molecular structure, the alpha-tocopherol contains long hydrophobic groups, and the carboxylate surfactant has the advantages of low irritation, good biocompatibility and the like. If the alpha-tocopherol is introduced into the structure of the carboxylate surfactant, a high-quality surfactant product with good affinity, good biodegradability and low skin irritation is hopeful to be obtained, and the product meets the requirements of current green chemical development. However, to date, there have been no reports of alpha-tocopherol surfactants.
Disclosure of Invention
[ technical problem ]:
most of the traditional low-foam surfactants are nonionic surfactants of ethylene oxide-propylene oxide block polyether type, and the surfactants are mainly prepared from petrochemicals, but nowadays, petroleum resources are in short supply. The vitamin E has the characteristics of low price, easy obtainment, reproducibility, biodegradability and the like. The alpha-tocopherol is introduced into the structure of the carboxylate surfactant, so that a high-quality surfactant product with good affinity, good biodegradability and low skin irritation is hopeful to be obtained, and the requirements of current green chemical development are met. However, to date, there have been no reports of alpha-tocopherol surfactants.
[ technical solution ]:
in order to achieve the above objects, the present invention provides a low foaming alpha-tocopherol surfactant and a method for preparing the same, which is a surfactant synthesized from alpha-tocopherol, which is a main component of vitamin E, as a raw material, and which exhibits excellent aggregation ability and high efficiency of reducing surface tension, and which has extremely low foaming and foam stabilizing properties.
The invention provides a compound, which has a structural formula shown as the following formula I:
Figure BDA0002561666390000021
wherein M is Na or K.
The invention provides a method for preparing the compound, and the synthetic route of the compound is as follows:
Figure BDA0002561666390000022
wherein R is selected from C2H5,C3H7,C4H9,C5H11X is selected from any one of Cl, Br and I, and M is Na or K.
In one embodiment of the invention, the synthesis of the compound is as follows:
(1) mixing alpha-tocopherol and 2-ethyl haloate, and reacting under the catalysis of potassium carbonate to obtain alpha-tocopherol acid ester, which is marked as a compound 1;
(2) and (2) reacting the alpha-tocopherol acid ester obtained in the step (1) with NaOH or KOH to obtain a target product alpha-tocopherol carboxylate, and marking as a compound 2, namely the final product.
In one embodiment of the present invention, the specific synthetic procedure for the compound is as follows:
(1) synthesis of Compound 1: get K2CO3Placed in a reaction vessel under N2Adding α -tocopherol dissolved in aprotic solvent under protection, stirring, adding 2-halogenated acid ethyl ester dissolved in aprotic solvent, heating to 50-70 deg.C, and reacting2CO3Filtering to remove the aprotic solvent, extracting with petroleum ether, collecting the organic phase after liquid separation, removing the petroleum ether, and further purifying to obtain a purified compound 1;
(2) synthesis of Compound 2: adding the purified compound 1 into a reaction container, adding ethanol and NaOH/KOH for reaction at 70-95 ℃, standing and cooling the mixture after the reaction is finished, removing supernatant, washing the residual product with acetone/ethanol mixed solution, and drying in vacuum to obtain light yellow solid, namely the final product compound 2.
In one embodiment of the present invention, the aprotic solvent in step (1) is DMF or acetone.
In one embodiment of the present invention, the stirring method in step (1) is: stirring for 15-60 min at room temperature.
In one embodiment of the present invention, whether the reaction in step (1) is completed or not is monitored by TLC.
In one embodiment of the present invention, the aprotic solvent is removed in step (1) by rotary evaporation using a vacuum rotary evaporator under boiling water bath conditions at 0.1 MPa.
In one embodiment of the present invention, the extraction method in step (1) is: extracting with petroleum ether in ice water.
In one embodiment of the present invention, the method for removing petroleum ether in the organic phase in step (1) is to use a vacuum rotary evaporator to rotary evaporate petroleum ether in the organic phase.
In one embodiment of the present invention, the purification method in step (1) is a purification through a 300-400 mesh silica gel chromatography column.
The invention provides a metal cleaning agent which contains the alpha-tocopherol surfactant.
The invention provides a cleaning agent for kitchen supplies, which contains the alpha-tocopherol surfactant.
The invention provides a laundry detergent which contains the alpha-tocopherol surfactant.
The present invention provides a personal care product comprising the above-described alpha-tocopherol surfactant.
[ advantageous effects ]:
(1) the invention takes α -tocopherol as raw material, and obtains a carboxylate surfactant through a series of synthetic steps, wherein the critical micelle concentration of the surfactant at 25 ℃ is 3.89 mmol.L-1,C200.27 mmol. multidot.L-1It shows excellent aggregating ability and high surface tension reducing efficiency. The surfactant has very low foaming and foam stabilizing properties. The initial foam volume is only 0.5ml, the half-life period of the foam is less than 3 seconds, and the foam can be applied to the fields of metal cleaning agents, personal washing and protecting articles and the like.
(2) Meanwhile, the alpha-tocopherol surfactant prepared by the invention is a high-quality surfactant product with good affinity, good biodegradability and low skin irritation. The carboxylate surfactant is widely used due to its advantages of mildness, low irritation, good biocompatibility and the like. Alpha-tocopherol is the most important active compound in vitamin E extracted from natural products, so that the alpha-tocopherol has good biodegradability. The carboxylate surfactant synthesized by using the surfactant as a raw material has the advantages of good biodegradability, good affinity of the carboxylate surfactant and low skin irritation.
Drawings
Fig. 1 is a molecular structure of an α -tocopherol surfactant prepared in example 1.
FIG. 2 is a NMR spectrum of alpha-tocopherol surfactant prepared in example 1.
FIG. 3 is a graph of the surface tension γ of the α -tocopherol surfactant prepared in example 1 as a function of concentration C (25 ℃).
FIG. 4 is a photograph (25 ℃) of foams of various concentrations of the alpha-tocopherol surfactant prepared in example 1.
FIG. 5 shows 4 mmol. L-1Graph (25 ℃) of the particle size distribution of the α -tocopherol surfactant solution prepared in example 1.
FIG. 6 shows 6 mmol. multidot.L prepared in comparative example 1-1Photograph of sodium laurate foam (25 ℃).
Detailed Description
Embodiments of the present invention will be described in detail below with reference to examples, but those skilled in the art will appreciate that the following examples are only illustrative of the present invention and should not be construed as limiting the scope of the present invention.
[ example 1 ]
Synthesis of compound 1: 7.7g (0.056mol) of K2CO3Put into a 250mL three-necked bottle at N219.8g (0.046mol) of α -tocopherol in DMF are added thereto under protection, stirred at room temperature for 30min, 9.3g (0.056mol) of ethyl 2-bromoacetate in DMF are added, the temperature is raised to 50 ℃ and the progress of the reaction is monitored by TLC2CO3Filtering, removing DMF at 90rad/min with a vacuum rotary evaporator under the condition of 0.1MPa in a boiling water bath, extracting with petroleum ether and ice water, collecting the organic phase after liquid separation, removing the solvent petroleum ether in the organic phase at 85rad/min with a vacuum rotary evaporator at 0.1MPa and 60-70 ℃, and adding the following components in parts by weight: ethyl acetate 10:1 as eluent was purified through a 300-400 mesh silica gel chromatography column.
Synthesis of Compound 2: 16.3g (0.031mol) of purified compound 1 were added to a 250mL single-neck flask, and 80mL of ethanol and 1.22g (0.031mol) of NaOH were added and reacted at 70 ℃. And (3) after the reaction is finished, standing and cooling the mixture, pouring supernatant liquor, washing the product by using an acetone/ethanol solution, and drying in vacuum to obtain a light yellow solid, namely the alpha-tocopherol surfactant. Fig. 1 shows the molecular structure of the α -tocopherol surfactant prepared in this example.
Structure and purity determination of alpha-tocopherol surfactants:
weighing appropriate amount of α -tocopherol, placing in a nuclear magnetic tube, and adding deuterated reagent CDCl3And (4) dissolving. Using an AduranceIII NMR spectrometer at 25 deg.C1And (3) performing H NMR (nuclear magnetic resonance) testing,1the resonance frequency of H was 400MHz, FIG. 2 is the hydrogen nuclear magnetic resonance spectrum of α -tocopherol surfactant prepared in this example, and it can be seen from FIG. 2 that the chemical shift of each hydrogen coincides with that of the target product α -tocopherol, indicating that the final product was obtained.
Measurement of surface tension of alpha-tocopherol surfactant:
respectively prepared into 0.002, 0.003, 0.006, 0.01, 0.02, 0.03, 0.06, 0.1, 0.2, 0.3, 0.6, 1, 2, 3, 6, 10 mmol.L-1The surface tension of the surfactant aqueous solution with the concentration is measured by a ring-hanging method at 25 ℃, each point is repeated for 3 times, the average value is taken, the change relation curve of the surface tension of the sample along with the concentration is drawn, the corresponding concentration at the turning point is the critical micelle concentration of the surfactant, figure 3 is the surface tension gamma of the α -tocopherol surfactant prepared by the embodiment along with the change curve of the concentration C (25 ℃), as can be seen from figure 3, the critical micelle concentration of the α -tocopherol surfactant at 25 ℃ is 3.89 mmol.L-1The surface tension of water is reduced by 20mN · m-1Corresponding to the surfactant concentration (C)20) 0.27 mmol. multidot.L-1
Measurement of foam properties of alpha-tocopherol surfactants:
10mL of 2, 4, 6 mmol. multidot.L was prepared-1An aqueous solution of α -tocopherol surfactant at a concentration was placed in a 100mL stoppered cylinder, shaken vigorously 25 times and allowed to stand, and the lather volume of the surfactant was recorded at 25 ℃ as a function of time.
FIG. 4 is a photograph (25 ℃) of foams of α -tocopherol surfactant of different concentrations prepared in this example, and it can be seen from FIG. 4 that as the concentration increases, the foam height rises from 0 to 0.5mL at 6 mmol.L-1The foam half-life (the half-life of the foam as the height of the foam drops to the initial height) at the concentration is less than 3 seconds.
4mmol·L-1α -determination of aggregate particle size in aqueous solutions of tocopherol surfactants:
configuration 4 mmol. L-1α -aqueous solution of tocopherol surfactant, scanning the particle size distribution of the solution at 25 deg.C with a particle size analyzer, as can be seen from FIG. 4, the solution has opalescence, and FIG. 5 is 4 mmol. L-1α -tocopherol surfactant solution (25 deg.C), as can be seen from FIG. 5, the particle size of the surfactant is uniformly distributed at 240-250nm, and it is inferred that vesicles around 240nm are formed.
[ example 2 ]
Synthesizing the low-foam facial cleanser:
20 wt% of carborpol941 diluted to 1 wt% is dissolved in 10 wt% of glycerol and then dissolved in 1.2 wt% of alpha-tocopherol surfactant in water to serve as a water phase, and 3 wt% of octadecanol, 1 wt% of beeswax, 2 wt% of polyoxyethylene soyamine (S2), 2 wt% of ceteareth alcohol (S21), 10 wt% of white oil, 2 wt% of squalane and 0.2 wt% of ethylparaben are uniformly mixed to serve as an oil phase. Respectively heating the water phase and the oil phase to 90 ℃, pouring the oil phase into the water phase while stirring, homogenizing for 1min by a homogenizer, slowly cooling in a water bath, adding 0.15 wt% of triethanolamine and the balance of water at 50 ℃, stirring until frosting, and standing to obtain the low-foam facial cleanser with the alpha-tocopherol surfactant as the main effective component.
Measurement of foam performance of the low-foam facial cleanser:
with 150mg/kg CaCl2Hard water the low foaming facial cleanser was formulated as a 3g/kg dilute solution. Adding 200mL of solution heated to 40 ℃ into a burette of a Roche foam instrument, allowing the solution to flow down along the central line of a graduated burette, starting timing and reading the foam height after the solution flows out, stopping when the foam height is half of the initial height, and repeating3 times. The low-foaming facial cleanser has the initial foam height of 0.5mL and the foam half-life period of less than 1 second.
Comparative example 1
Determination of the foam Properties of sodium laurate:
10mL of 6 mmol. L was prepared-1The aqueous sodium laurate solution with a concentration is placed in a measuring cylinder with a plug of 100mL, shaken vigorously for 25 times and then left to stand, and the foam volume of the surfactant is recorded at 25 ℃ as a function of time.
FIG. 6 shows 6 mmol. multidot.L of a compound prepared in this comparative example-1Photograph (25 ℃) of the sodium laurate foam, and as can be seen from FIG. 6, the foam height was 31 ml. At 6 mmol. multidot.L-1The foam half-life (the half-life of the foam as the height of the foam drops to the initial height) at the concentration was 27 minutes.
Although the present invention has been described with reference to the preferred embodiments, it should be understood that various changes and modifications can be made therein by those skilled in the art without departing from the spirit and scope of the invention as defined in the appended claims.

Claims (10)

1. A compound having the formula i:
Figure FDA0002561666380000011
wherein M is Na or K.
2. A method for synthesizing the compound of claim 1, wherein the compound is synthesized by the following route:
Figure FDA0002561666380000012
wherein R is selected from C2H5,C3H7,C4H9,C5H11Wherein X is ClBr and I, and M is Na or K.
3. The method of claim 2, wherein the compound is synthesized by the steps of:
(1) mixing alpha-tocopherol and 2-ethyl haloate, and reacting under the catalysis of potassium carbonate to obtain alpha-tocopherol acid ester, which is marked as a compound 1;
(2) and (2) reacting the alpha-tocopherol acid ester obtained in the step (1) with NaOH or KOH to obtain a target product alpha-tocopherol carboxylate, and marking as a compound 2, namely the final product.
4. The method according to claim 2 or 3, wherein the specific synthetic steps of the compound are as follows:
(1) synthesis of Compound 1: get K2CO3Placed in a reaction vessel under N2Adding α -tocopherol dissolved in aprotic solvent under protection, stirring, adding 2-halogenated acid ethyl ester dissolved in aprotic solvent, heating to 50-70 deg.C, and reacting2CO3Filtering to remove the aprotic solvent, extracting with petroleum ether, collecting the organic phase after liquid separation, removing the petroleum ether, and further purifying to obtain a purified compound 1;
(2) synthesis of Compound 2: adding the purified compound 1 into a reaction container, adding ethanol and NaOH/KOH for reaction at 70-95 ℃, standing and cooling the mixture after the reaction is finished, removing supernatant, washing the residual product with acetone/ethanol mixed solution, and drying in vacuum to obtain light yellow solid, namely the final product compound 2.
5. The process of claim 4, wherein the aprotic solvent in step (1) is DMF or acetone.
6. The method as claimed in claim 4, wherein the purification in step (1) is performed by using a 300-400 mesh silica gel chromatography column.
7. A metal cleaner characterized by containing the compound according to claim 1.
8. A cleaning agent for kitchenware, characterized in that it comprises the compound as claimed in claim 1.
9. A laundry detergent comprising a compound of claim 1.
10. A personal care product comprising a compound according to claim 1.
CN202010615372.0A 2020-06-30 2020-06-30 Low-foam alpha-tocopherol surfactant and preparation method thereof Pending CN111635390A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202010615372.0A CN111635390A (en) 2020-06-30 2020-06-30 Low-foam alpha-tocopherol surfactant and preparation method thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202010615372.0A CN111635390A (en) 2020-06-30 2020-06-30 Low-foam alpha-tocopherol surfactant and preparation method thereof

Publications (1)

Publication Number Publication Date
CN111635390A true CN111635390A (en) 2020-09-08

Family

ID=72327996

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202010615372.0A Pending CN111635390A (en) 2020-06-30 2020-06-30 Low-foam alpha-tocopherol surfactant and preparation method thereof

Country Status (1)

Country Link
CN (1) CN111635390A (en)

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020107207A1 (en) * 1998-09-23 2002-08-08 Sanders Bob G. Tocopherols, tocotrienols, other chroman and side chain derivatives and uses thereof
WO2002076938A2 (en) * 2001-03-23 2002-10-03 Sonus Pharmaceuticals, Inc. Carboxybenzopyran derivatives and compositions
CN102516258A (en) * 2011-11-11 2012-06-27 南京美西宁医药科技有限责任公司 Water-soluble vitamin E derivative modified fat-soluble anti-cancer drug compound and preparation, preparation method and application of compound
CN103611471A (en) * 2013-12-06 2014-03-05 江南大学 Carboxylate surfactant containing aryl groups and preparation method thereof
WO2015035212A1 (en) * 2013-09-06 2015-03-12 Research Development Foundation Alpha-tea salt forms: compositions and uses for treating disease

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020107207A1 (en) * 1998-09-23 2002-08-08 Sanders Bob G. Tocopherols, tocotrienols, other chroman and side chain derivatives and uses thereof
WO2002076938A2 (en) * 2001-03-23 2002-10-03 Sonus Pharmaceuticals, Inc. Carboxybenzopyran derivatives and compositions
CN102516258A (en) * 2011-11-11 2012-06-27 南京美西宁医药科技有限责任公司 Water-soluble vitamin E derivative modified fat-soluble anti-cancer drug compound and preparation, preparation method and application of compound
WO2015035212A1 (en) * 2013-09-06 2015-03-12 Research Development Foundation Alpha-tea salt forms: compositions and uses for treating disease
CN103611471A (en) * 2013-12-06 2014-03-05 江南大学 Carboxylate surfactant containing aryl groups and preparation method thereof

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
彭小芹 主编: "《无机材料性能学基础》", 28 February 2020, 重庆大学出版社 *
雷炳福: "α-生育酚酯类产品及其制备方法", 《西部粮油科技》 *

Similar Documents

Publication Publication Date Title
JPWO2007088702A1 (en) Fatty acid alkyl ester production method and fatty acid alkyl ester production apparatus
CN1065458A (en) Polyethoxylated vitamin E and its production and use
CN110372483A (en) A kind of catalytic oxidation of cyclopentene prepares the process of glutaraldehyde
WO2022048099A1 (en) Method for preparing narrow-distribution triethanolamine block polyether, block polyether, and use thereof
CN109679678A (en) Alkalinity/non basic nitrogen eutectic solvent and method are extracted from analog gasoline
JP4246252B2 (en) Surfactant composition
CN102351968B (en) Method for preparing polymer by atom transfer radical polymerization method
CN111635390A (en) Low-foam alpha-tocopherol surfactant and preparation method thereof
CN106810584A (en) The synthetic method of Altrenogest
CN102671687B (en) Composite metal nitrogen-doped carbon nanotube catalyst, preparation method thereof and method for catalyzing biodiesel by utilizing catalyst
CN104945606B (en) A kind of preparation method of Polyester Defoamer
CN101703906B (en) Cationic gemini surfactant containing tri-ester groups and preparation method thereof
CN109053640A (en) A method of gamma-valerolactone is prepared by levulic acid and its esters
CN108003123A (en) A kind of synthetic method of coumarin kind compound
CN108707228A (en) A kind of preparation method of hydroxyl polyethylene glycol propionic ester
KR101488862B1 (en) Method For Preparing Alkyl Polyglycoside
CN114350383A (en) Novel fatty alcohol ether carboxylic acid surfactant and preparation method thereof
CN106518867A (en) Refining method for apixaban
CN106674177A (en) Synthesis method of 7-acryloyloxy-4-methylcoumarin
CN105859496A (en) Green synthesis method of acetal-type or ketal-type compound
CN114685401A (en) Synthesis method of di (4-methylpiperazine-1-yl) ketone
CN109651255A (en) A kind of glyoxaline ion liquid and its preparation and the application in vitamin e acetate synthesizes
CN114507206B (en) DL-alpha-tocopherol D-glucose amide nonionic surfactant and preparation method thereof
CN111072745A (en) Preparation method of 6-methylene-7-ketocholic acid
CN106268886A (en) A kind of carbon-doped mesoporous aluminum phosphate and its preparation method and application

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication

Application publication date: 20200908

RJ01 Rejection of invention patent application after publication